Most topical formulations developed today are complex and require tight control to be chemically and physically stable while meeting the targeted efficiency and delivering pleasant aesthetics. To deliver on-time and on-budget, fully characterized active pharmaceutical ingredient (API) and formulation characteristics are required to support scale up and clinical testing.
Determination of active substance properties early in development e.g. solid state characterization and salt and polymorph screening, impurity profile, ensures a well-characterized API. This provides a reliable foundation around which the formulation can be created while facilitating efficient and effective product development and reducing risk. These approaches aid in reducing overall timelines and costs.
Interested in learning how integrated formulation and chemistry services can benefit your topical products?
In this 45-minute presentation, Dr. Gareth Winckle, Head of Formulation, and Dr. Jean-Guy Boiteau, Head of Chemical Development, will cover:
• Identify key chemical and formulation development steps and strategies that enable creative, innovative and pragmatic project progression:
- API characterization strategies: solid form characterization, impurity profiling, incompatibility assessments
- Target product profile and formulation strategy
- Criticality of raw material selection
- Preformulation: Solubility and compatibility (API – excipient interaction)
- Trouble shooting: Identification of degradation pathways and recommendation of preventative approaches
• Nuvisan services
- Chemical development and topical formulation development expertise, technical capacity and equipment and know-how.
- Benefits of Integrated chemical development and topical formulation services and other advantages of our ‘all under one roof’ service
• Live Q&A session
Can't join? Don't worry, register anyway, the slides and recording will be sent to you after the webinar.